Clinical Trials List
2019-04-01 - 2027-11-30
Phase II
Recruiting5
ICD-10C25.9
Malignant neoplasm of pancreas, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9157.9
Malignant neoplasm of pancreas, part unspecified
-
Trial Applicant
ICON Clinical Research Pte Ltd
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Shang-Wen Chen Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- San-Chi Chen Division of General Internal Medicine
- Hung-Yuan Yu Division of General Internal Medicine
- Pei-Chang Lee Division of Hematology & Oncology
- Ming-Huang Chen Division of General Internal Medicine
- 李癸汌 Division of General Internal Medicine
- Yee Chao Division of General Internal Medicine
- 姜乃榕 Division of General Internal Medicine
- Yi-Ping Hung Division of General Internal Medicine
- Yun-Cheng Hsieh Division of General Internal Medicine
- Shao-Jung Hsu Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-Lun Chang Division of Hematology & Oncology
- Chih-Shiang Chang Digestive System Department
- Tzu-Yao Liao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 莊博雅 Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
- Wei-Hong Cheng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Ching Chen Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
369 participants
